Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Adult Malignant Glioma Therapeutics Market Size Growth Rate by Type (2014-2025) 1.4.2 Glioblastoma Multiforme 1.4.3 Anaplastic Astrocytoma 1.4.4 Anaplastic Oligodendroglioma 1.4.5 Other 1.5 Market by Application 1.5.1 Global Adult Malignant Glioma Therapeutics Market Share by Application (2019-2025) 1.5.2 Hospitals 1.5.3 Specialty Clinics 1.5.4 Cancer and Radiation Therapy Centers 1.5.5 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Adult Malignant Glioma Therapeutics Market Size 2.2 Adult Malignant Glioma Therapeutics Growth Trends by Regions 2.2.1 Adult Malignant Glioma Therapeutics Market Size by Regions (2019-2025) 2.2.2 Adult Malignant Glioma Therapeutics Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 3 Market Share by Key Players 3.1 Adult Malignant Glioma Therapeutics Market Size by by Players 3.1.1 Global Adult Malignant Glioma Therapeutics Revenue by by Players (2014-2019) 3.1.2 Global Adult Malignant Glioma Therapeutics Revenue Market Share by by Players (2014-2019) 3.1.3 Global Adult Malignant Glioma Therapeutics Market Concentration Ratio (CR5 and HHI) 3.2 Adult Malignant Glioma Therapeutics Key Players Head office and Area Served 3.3 Key Players Adult Malignant Glioma Therapeutics Product/Solution/Service 3.4 Date of Enter into Adult Malignant Glioma Therapeutics Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Adult Malignant Glioma Therapeutics Market Size by Type (2014-2019) 4.2 Global Adult Malignant Glioma Therapeutics Market Size by Application (2014-2019) 5 North America 5.1 North America Adult Malignant Glioma Therapeutics Market Size (2014-2019) 5.2 Adult Malignant Glioma Therapeutics Key Players in North America 5.3 North America Adult Malignant Glioma Therapeutics Market Size by Type 5.4 North America Adult Malignant Glioma Therapeutics Market Size by Application 6 Europe 6.1 Europe Adult Malignant Glioma Therapeutics Market Size (2014-2019) 6.2 Adult Malignant Glioma Therapeutics Key Players in Europe 6.3 Europe Adult Malignant Glioma Therapeutics Market Size by Type 6.4 Europe Adult Malignant Glioma Therapeutics Market Size by Application 7 China 7.1 China Adult Malignant Glioma Therapeutics Market Size (2014-2019) 7.2 Adult Malignant Glioma Therapeutics Key Players in China 7.3 China Adult Malignant Glioma Therapeutics Market Size by Type 7.4 China Adult Malignant Glioma Therapeutics Market Size by Application 8 Japan 8.1 Japan Adult Malignant Glioma Therapeutics Market Size (2014-2019) 8.2 Adult Malignant Glioma Therapeutics Key Players in Japan 8.3 Japan Adult Malignant Glioma Therapeutics Market Size by Type 8.4 Japan Adult Malignant Glioma Therapeutics Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Adult Malignant Glioma Therapeutics Market Size (2014-2019) 9.2 Adult Malignant Glioma Therapeutics Key Players in Southeast Asia 9.3 Southeast Asia Adult Malignant Glioma Therapeutics Market Size by Type 9.4 Southeast Asia Adult Malignant Glioma Therapeutics Market Size by Application 10 India 10.1 India Adult Malignant Glioma Therapeutics Market Size (2014-2019) 10.2 Adult Malignant Glioma Therapeutics Key Players in India 10.3 India Adult Malignant Glioma Therapeutics Market Size by Type 10.4 India Adult Malignant Glioma Therapeutics Market Size by Application 11 Central & South America 11.1 Central & South America Adult Malignant Glioma Therapeutics Market Size (2014-2019) 11.2 Adult Malignant Glioma Therapeutics Key Players in Central & South America 11.3 Central & South America Adult Malignant Glioma Therapeutics Market Size by Type 11.4 Central & South America Adult Malignant Glioma Therapeutics Market Size by Application 12 International Players Profiles 12.1 Merck 12.1.1 Merck Company Details 12.1.2 Company Description and Business Overview 12.1.3 Adult Malignant Glioma Therapeutics Introduction 12.1.4 Merck Revenue in Adult Malignant Glioma Therapeutics Business (2014-2019)) 12.1.5 Merck Recent Development 12.2 Hoffmann-La Roche 12.2.1 Hoffmann-La Roche Company Details 12.2.2 Company Description and Business Overview 12.2.3 Adult Malignant Glioma Therapeutics Introduction 12.2.4 Hoffmann-La Roche Revenue in Adult Malignant Glioma Therapeutics Business (2014-2019) 12.2.5 Hoffmann-La Roche Recent Development 12.3 Arbor Pharmaceuticals 12.3.1 Arbor Pharmaceuticals Company Details 12.3.2 Company Description and Business Overview 12.3.3 Adult Malignant Glioma Therapeutics Introduction 12.3.4 Arbor Pharmaceuticals Revenue in Adult Malignant Glioma Therapeutics Business (2014-2019) 12.3.5 Arbor Pharmaceuticals Recent Development 12.4 Pfizer 12.4.1 Pfizer Company Details 12.4.2 Company Description and Business Overview 12.4.3 Adult Malignant Glioma Therapeutics Introduction 12.4.4 Pfizer Revenue in Adult Malignant Glioma Therapeutics Business (2014-2019) 12.4.5 Pfizer Recent Development 12.5 AbbVie 12.5.1 AbbVie Company Details 12.5.2 Company Description and Business Overview 12.5.3 Adult Malignant Glioma Therapeutics Introduction 12.5.4 AbbVie Revenue in Adult Malignant Glioma Therapeutics Business (2014-2019) 12.5.5 AbbVie Recent Development 12.6 Amgen 12.6.1 Amgen Company Details 12.6.2 Company Description and Business Overview 12.6.3 Adult Malignant Glioma Therapeutics Introduction 12.6.4 Amgen Revenue in Adult Malignant Glioma Therapeutics Business (2014-2019) 12.6.5 Amgen Recent Development 12.7 Bristol-Myers Squibb 12.7.1 Bristol-Myers Squibb Company Details 12.7.2 Company Description and Business Overview 12.7.3 Adult Malignant Glioma Therapeutics Introduction 12.7.4 Bristol-Myers Squibb Revenue in Adult Malignant Glioma Therapeutics Business (2014-2019) 12.7.5 Bristol-Myers Squibb Recent Development 12.8 Sun Pharmaceutical 12.8.1 Sun Pharmaceutical Company Details 12.8.2 Company Description and Business Overview 12.8.3 Adult Malignant Glioma Therapeutics Introduction 12.8.4 Sun Pharmaceutical Revenue in Adult Malignant Glioma Therapeutics Business (2014-2019) 12.8.5 Sun Pharmaceutical Recent Development 12.9 Teva Pharmaceutical 12.9.1 Teva Pharmaceutical Company Details 12.9.2 Company Description and Business Overview 12.9.3 Adult Malignant Glioma Therapeutics Introduction 12.9.4 Teva Pharmaceutical Revenue in Adult Malignant Glioma Therapeutics Business (2014-2019) 12.9.5 Teva Pharmaceutical Recent Development 12.10 Novocure 12.10.1 Novocure Company Details 12.10.2 Company Description and Business Overview 12.10.3 Adult Malignant Glioma Therapeutics Introduction 12.10.4 Novocure Revenue in Adult Malignant Glioma Therapeutics Business (2014-2019) 12.10.5 Novocure Recent Development 12.11 Eli Lilly 12.12 AstraZeneca 12.13 Novartis AG 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Product (2019-2025) 13.2 Market Size Forecast by Application (2019-2025) 13.3 Market Size Forecast by Regions 13.4 North America 13.5 Europe 13.6 China 13.7 Japan 13.8 Southeast Asia 13.9 India 13.10 Central & South America 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 15.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Adult Malignant Glioma Therapeutics Key Market Segments Table Key Players Adult Malignant Glioma Therapeutics Covered Table Global Adult Malignant Glioma Therapeutics Market Size Growth Rate by Type 2018-2025 (Million US$) Figuer Glioblastoma Multiforme Figures Table Key Players of Glioblastoma Multiforme Figuer Anaplastic Astrocytoma Figures Table Key Players of Anaplastic Astrocytoma Figuer Anaplastic Oligodendroglioma Figures Table Key Players of Anaplastic Oligodendroglioma Figuer Other Figures Table Key Players of Other Table Global Adult Malignant Glioma Therapeutics Market Size Growth by Application 2019-2025 (Million US$) Figure Global Adult Malignant Glioma Therapeutics Market Share by Application in 2018 & 2025 Figure Hospitals Case Studies Figure Specialty Clinics Case Studies Figure Cancer and Radiation Therapy Centers Case Studies Figure Others Case Studies Figure Adult Malignant Glioma Therapeutics Report Years Considered Figure Global Adult Malignant Glioma Therapeutics Market Size and Growth Rate 2014-2025 (Million US$) Table Global Adult Malignant Glioma Therapeutics Market Size by Regions 2019-2025 (Million US$) Table Global Adult Malignant Glioma Therapeutics Market Size by Regions 2019-2025 (Million US$) Table Global Adult Malignant Glioma Therapeutics Market Share by Regions 2014-2019 Figure Global Adult Malignant Glioma Therapeutics Market Share by Regions 2014-2019 Figure Global Adult Malignant Glioma Therapeutics Market Share by Regions in 2018 Table Market Top Trends Table Key Drivers: Impact Analysis (2019-2025) Table Key Challenges Figure PORTER'S FIVE FORCES ANALYSIS Table Global Adult Malignant Glioma Therapeutics Revenue by by Players (2014-2019) (Million US$) Table Global Adult Malignant Glioma Therapeutics Market Share by by Players (2014-2019) Figure Global Adult Malignant Glioma Therapeutics Market Share by by Players in 2018 Table Global Adult Malignant Glioma Therapeutics by Players Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Adult Malignant Glioma Therapeutics Product/Solution/Service Table Date of Enter into Adult Malignant Glioma Therapeutics Market Table Mergers & Acquisitions, Expansion Plans Table Global Adult Malignant Glioma Therapeutics Market Size by Type (2014-2019) (Million US$) Table Global Adult Malignant Glioma Therapeutics Market Size Share by Type (2014-2019) Figure Global Adult Malignant Glioma Therapeutics Market Size Market Share by Type (2014-2019) Table Global Adult Malignant Glioma Therapeutics Market Size by Application (2014-2019) (Million US$) Table Global Adult Malignant Glioma Therapeutics Market Size Share by Application (2014-2019) Figure Global Adult Malignant Glioma Therapeutics Market Size Market Share by Application (2014-2019) Figure Global Adult Malignant Glioma Therapeutics Revenue Market Share by Application in 2018 Figure North America Adult Malignant Glioma Therapeutics Market Size 2014-2019 (Million US$) Table North America Key Players Adult Malignant Glioma Therapeutics Revenue (2018-2019) (Million US$) Table North America Key Players Adult Malignant Glioma Therapeutics Market Share (2018-2019) Table North America Adult Malignant Glioma Therapeutics Market Size by Type 2014-2019 (Million US$) Table North America Adult Malignant Glioma Therapeutics Market Share by Type 2014-2019 Table North America Adult Malignant Glioma Therapeutics Market Size by Application 2014-2019 (Million US$) Table North America Adult Malignant Glioma Therapeutics Market Share by Application 2014-2019 Figure Europe Adult Malignant Glioma Therapeutics Market Size 2014-2019 (Million US$) Table Europe Key Players Adult Malignant Glioma Therapeutics Revenue (2018-2019) (Million US$) Table Europe Key Players Adult Malignant Glioma Therapeutics Market Share (2018-2019) Table Europe Adult Malignant Glioma Therapeutics Market Size by Type 2014-2019 (Million US$) Table Europe Adult Malignant Glioma Therapeutics Market Share by Type 2014-2019 Table Europe Adult Malignant Glioma Therapeutics Market Size by Application 2014-2019 (Million US$) Table Europe Adult Malignant Glioma Therapeutics Market Share by Application 2014-2019 Figure China Adult Malignant Glioma Therapeutics Market Size 2014-2019 (Million US$) Table China Key Players Adult Malignant Glioma Therapeutics Revenue (2018-2019) (Million US$) Table China Key Players Adult Malignant Glioma Therapeutics Market Share (2018-2019) Table China Adult Malignant Glioma Therapeutics Market Size by Type 2014-2019 (Million US$) Table China Adult Malignant Glioma Therapeutics Market Share by Type 2014-2019 Table China Adult Malignant Glioma Therapeutics Market Size by Application 2014-2019 (Million US$) Table China Adult Malignant Glioma Therapeutics Market Share by Application 2014-2019 Figure Japan Adult Malignant Glioma Therapeutics Market Size 2014-2019 (Million US$) Table Japan Key Players Adult Malignant Glioma Therapeutics Revenue (2018-2019) (Million US$) Table Japan Key Players Adult Malignant Glioma Therapeutics Market Share (2018-2019) Table Japan Adult Malignant Glioma Therapeutics Market Size by Type 2014-2019 (Million US$) Table Japan Adult Malignant Glioma Therapeutics Market Share by Type 2014-2019 Table Japan Adult Malignant Glioma Therapeutics Market Size by Application 2014-2019 (Million US$) Table Japan Adult Malignant Glioma Therapeutics Market Share by Application 2014-2019 Figure Southeast Asia Adult Malignant Glioma Therapeutics Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Adult Malignant Glioma Therapeutics Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Adult Malignant Glioma Therapeutics Market Share (2018-2019) Table Southeast Asia Adult Malignant Glioma Therapeutics Market Size by Type 2014-2019 (Million US$) Table Southeast Asia Adult Malignant Glioma Therapeutics Market Share by Type 2014-2019 Table Southeast Asia Adult Malignant Glioma Therapeutics Market Size by Application 2014-2019 (Million US$) Table Southeast Asia Adult Malignant Glioma Therapeutics Market Share by Application 2014-2019 Figure India Adult Malignant Glioma Therapeutics Market Size 2014-2019 (Million US$) Table India Key Players Adult Malignant Glioma Therapeutics Revenue (2018-2019) (Million US$) Table India Key Players Adult Malignant Glioma Therapeutics Market Share (2018-2019) Table India Adult Malignant Glioma Therapeutics Market Size by Type 2014-2019 (Million US$) Table India Adult Malignant Glioma Therapeutics Market Share by Type 2014-2019 Table India Adult Malignant Glioma Therapeutics Market Size by Application 2014-2019 (Million US$) Table India Adult Malignant Glioma Therapeutics Market Share by Application 2014-2019 Figure Central & South America Adult Malignant Glioma Therapeutics Market Size 2014-2019 (Million US$) Table Central & South America Key Players Adult Malignant Glioma Therapeutics Revenue (2018-2019) (Million US$) Table Central & South America Key Players Adult Malignant Glioma Therapeutics Market Share (2018-2019) Table Central & South America Adult Malignant Glioma Therapeutics Market Size by Type 2014-2019 (Million US$) Table Central & South America Adult Malignant Glioma Therapeutics Market Share by Type 2014-2019 Table Central & South America Adult Malignant Glioma Therapeutics Market Size by Application 2014-2019 (Million US$) Table Central & South America Adult Malignant Glioma Therapeutics Market Share by Application 2014-2019 Table Merck Company Details Table Merck Revenue in Adult Malignant Glioma Therapeutics Business 2014-2019 (Million US$) Figure Merck Revenue Growth Rate in Adult Malignant Glioma Therapeutics Business (2014-2019) Table Merck Recent Development Table Hoffmann-La Roche Company Details Table Hoffmann-La Roche Revenue in Adult Malignant Glioma Therapeutics Business 2014-2019 (Million US$) Figure Hoffmann-La Roche Revenue Growth Rate in Adult Malignant Glioma Therapeutics Business (2014-2019) Table Hoffmann-La Roche Recent Development Table Arbor Pharmaceuticals Company Details Table Arbor Pharmaceuticals Revenue in Adult Malignant Glioma Therapeutics Business 2014-2019 (Million US$) Figure Arbor Pharmaceuticals Revenue Growth Rate in Adult Malignant Glioma Therapeutics Business (2014-2019) Table Arbor Pharmaceuticals Recent Development Table Pfizer Company Details Table Pfizer Revenue in Adult Malignant Glioma Therapeutics Business 2014-2019 (Million US$) Figure Pfizer Revenue Growth Rate in Adult Malignant Glioma Therapeutics Business (2014-2019) Table Pfizer Recent Development Table AbbVie Company Details Table AbbVie Revenue in Adult Malignant Glioma Therapeutics Business 2014-2019 (Million US$) Figure AbbVie Revenue Growth Rate in Adult Malignant Glioma Therapeutics Business (2014-2019) Table AbbVie Recent Development Table Amgen Company Details Table Amgen Revenue in Adult Malignant Glioma Therapeutics Business 2014-2019 (Million US$) Figure Amgen Revenue Growth Rate in Adult Malignant Glioma Therapeutics Business (2014-2019) Table Amgen Recent Development Table Bristol-Myers Squibb Company Details Table Bristol-Myers Squibb Revenue in Adult Malignant Glioma Therapeutics Business 2014-2019 (Million US$) Figure Bristol-Myers Squibb Revenue Growth Rate in Adult Malignant Glioma Therapeutics Business (2014-2019) Table Bristol-Myers Squibb Recent Development Table Sun Pharmaceutical Company Details Table Sun Pharmaceutical Revenue in Adult Malignant Glioma Therapeutics Business 2014-2019 (Million US$) Figure Sun Pharmaceutical Revenue Growth Rate in Adult Malignant Glioma Therapeutics Business (2014-2019) Table Sun Pharmaceutical Recent Development Table Teva Pharmaceutical Company Details Table Teva Pharmaceutical Revenue in Adult Malignant Glioma Therapeutics Business 2014-2019 (Million US$) Figure Teva Pharmaceutical Revenue Growth Rate in Adult Malignant Glioma Therapeutics Business (2014-2019) Table Teva Pharmaceutical Recent Development Table Novocure Company Details Table Novocure Revenue in Adult Malignant Glioma Therapeutics Business 2014-2019 (Million US$) Figure Novocure Revenue Growth Rate in Adult Malignant Glioma Therapeutics Business (2014-2019) Table Novocure Recent Development Table Eli Lilly Company Details Table AstraZeneca Company Details Table Novartis AG Company Details Table Global Adult Malignant Glioma Therapeutics Market Size by Regions (Million US$) 2019-2025 Figure Global Adult Malignant Glioma Therapeutics Market Size Share by Regions (2019-2025) Figure Global Adult Malignant Glioma Therapeutics Market Size Share by Regions in 2025 Figure North America Adult Malignant Glioma Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Europe Adult Malignant Glioma Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure China Adult Malignant Glioma Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Japan Adult Malignant Glioma Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Adult Malignant Glioma Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure India Adult Malignant Glioma Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Adult Malignant Glioma Therapeutics Market Size Forecast (2019-2025)(Million USD) Table Global Adult Malignant Glioma Therapeutics Market Size by Product (2019-2025) (Million US$) Figure Global Adult Malignant Glioma Therapeutics Market Size by Product (2019-2025) Figure Global Adult Malignant Glioma Therapeutics Market Size by Product in 2025 Table Global Adult Malignant Glioma Therapeutics Market Size by Application (2019-2025) (Million US$) Figure Global Adult Malignant Glioma Therapeutics Market Size by Application (2019-2025) Figure Global Adult Malignant Glioma Therapeutics Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Merck Hoffmann-La Roche Arbor Pharmaceuticals Pfizer AbbVie Amgen Bristol-Myers Squibb Sun Pharmaceutical Teva Pharmaceutical Novocure Eli Lilly AstraZeneca Novartis AG